title: Succinylcholine-induced hyperkalemia in a patient with multiple sclerosis.
abstract: BACKGROUND
  Succinylcholine administration is associated with hyperkalemia in patients with a variety of medical conditions, including many neuromuscular disorders. Nonetheless, there is a paucity of literature describing hyperkalemia after the administration of succinylcholine to patients with multiple sclerosis.
  
  
  METHODS
  This case report describes a 38-year-old woman with multiple sclerosis who developed life-threatening hyperkalemia after the administration of succinylcholine during rapid sequence intubation.
  
  
  CONCLUSIONS
  This case highlights the potential for iatrogenic hyperkalemia after succinylcholine in patients with neurologic diseases, including multiple sclerosis.
authors.affiliation: Department of Emergency Medicine, Section of Medical Toxicology, University of Southern California, Los Angeles, California 90033, USA.
authors.forename: Michael
authors.initials: M
authors.lastname: Levine
authors.forename: David F M
authors.initials: DF
authors.lastname: Brown
mesh_terms: D000328:Adult; D004417:Dyspnea / Q000209:etiology / Q000628:therapy; D005260:Female; D006801:Humans; D006947:Hyperkalemia / Q000139:chemically induced* / Q000188:drug therapy; D007442:Intubation, Intratracheal / Q000009:adverse effects; D009103:Multiple Sclerosis / Q000150:complications*; D018908:Muscle Weakness / Q000209:etiology; D013390:Succinylcholine / Q000009:adverse effects*; D034941:Upper Extremity
chemical_list: D013390:Succinylcholine